biomedical research and drug development · BEGINNER LESSON
Preclinical
Preclinical refers to the stage of drug or toxicity testing done before a treatment is studied in people. It uses laboratory and animal models to measure safety, efficacy, and how a candidate behaves in the body, but it has known limits in predicting human outcomes.
What preclinical is and what it measures
Preclinical work is the stage before clinical testing in people. It includes laboratory studies (in vitro, meaning done in cells or test systems outside the body) and animal studies (in vivo, meaning in living organisms). Researchers measure whether a candidate shows expected effects, how toxic it is, and, in later preclinical work, how it is handled by the body through pharmacokinetics, toxicokinetics, and pharmacodynamics. Pharmacokinetics describes what the body does to a substance over time; toxicokinetics focuses on toxic exposure; pharmacodynamics describes what the substance does to the body. This stage is meant to find promising candidates and reduce risk before human use.
[1] pmc.ncbi.nlm.nih.gov · articles · PMC13424496Redefining preclinical testing: human-relevant alternatives ... [2] Bench to bedside: Bridging the gap [3] Operationalizing Precision Medicine in Drug Development
How it works
Traditional preclinical testing often starts with cell-based assays and then may move to animal models. Examples include receptor binding assays, the monocyte activation test, and enzyme-linked immunosorbent assays (ELISA, a test that detects or measures substances using antibody binding and a readout signal). Newer human-relevant methods include organoids, organ-on-a-chip systems, microphysiological systems, and artificial intelligence-powered computer models. Organ-on-a-chip systems and microphysiological systems use microfluidic devices, which are small channels that control tiny flows of liquid around cells. These approaches try to model human biology more directly than older animal-only testing.
[1] pmc.ncbi.nlm.nih.gov · articles · PMC13424496Redefining preclinical testing: human-relevant alternatives ... [2] Bench to bedside: Bridging the gap
Why preclinical results can fail to predict humans
Animal models are useful for studying disease mechanisms and testing ideas, but they often do not reproduce the full complexity of human disease. Sources note differences in genetics, immune complexity, organ anatomy, lifespan, and other biological features. Animal studies also tend to use inbred or genetically similar animals, while human populations vary widely in genetics, lifestyle, and environment. Because of this, results that look strong in animals may not translate well to patients. The sources also note that many promising animal studies do not lead to successful human outcomes.
[1] pmc.ncbi.nlm.nih.gov · articles · PMC13424496Redefining preclinical testing: human-relevant alternatives ... [2] Bench to bedside: Bridging the gap
Limits and current direction
Preclinical methods are not a complete substitute for one another. Even validated human-relevant tests have limitations, so they are often used in combination rather than alone. The scientific and ethical push is toward methods that better match human biology while reducing animal use, in line with the 3Rs principle, which means replace, reduce, and refine animal use. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) are increasingly open to nonanimal methods when scientifically justified, but careful validation is still needed before a result is trusted for decision-making.
[1] pmc.ncbi.nlm.nih.gov · articles · PMC13424496Redefining preclinical testing: human-relevant alternatives ... [2] Bench to bedside: Bridging the gap [3] Operationalizing Precision Medicine in Drug Development
SEE THE IDEA
From candidate to preclinical evidence
A possible drug, vaccine, or toxic substance is chosen for study.
Cells, assays, organoids, or organ-on-a-chip systems measure activity and toxicity.
Living models add whole-body effects such as distribution and safety signals.
Differences from humans can reduce translation to clinical success.
The candidate moves through simpler to more complex systems, but each step still has limits in predicting human response.
Preclinical testing builds evidence before human studies, yet no single model fully captures human biology.
TRY IT YOURSELF
Test your understanding
Choose an answer, then check the explanation.
PUT IT TOGETHER
Match each concept to its meaning
Drag a label onto its description, or select a label and then select a description. This also works with a keyboard.
4 pairs to match
Sources and further reading
This general lesson was generated from public source material. It explains a concept; it does not interpret a private paper or provide medical advice.